Connor, Clark & Lunn Investment Management (CC&L)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.05M | Sell |
|
|||||
|
2024
Q4 | $10.5M | Buy |
|
|||||
|
2024
Q3 | $3.58M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.22M | Sell |
|
|||||
|
2023
Q4 | $77.1M | Buy |
|
|||||
|
2023
Q3 | $65.5M | Buy |
|
|||||
|
2023
Q2 | $2.53M | Buy |
|
|||||
|
2023
Q1 | $1.54M | Sell |
|
|||||
|
2022
Q4 | $34.9M | Buy |
|
|||||
|
2022
Q3 | $1.52M | Sell |
|
|||||
|
2022
Q2 | $20.6M | Sell |
|
|||||
|
2022
Q1 | $62.2M | Buy |
|
|||||
|
2021
Q4 | $45.6M | Buy |
|
|||||
|
2021
Q3 | $3.23M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $21.5M | Sell |
|
|||||
|
2020
Q2 | $46M | Sell |
|
|||||
|
2020
Q1 | $45.7M | Buy |
|
|||||
|
2019
Q4 | $238K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $37.2M | Buy |
|
|||||
|
2019
Q1 | $38.6M | Buy |
|
|||||
|
2018
Q4 | $32M | Buy |
|
|||||
|
2018
Q3 | $32.9M | Sell |
|
|||||
|
2018
Q2 | $35.4M | Buy |
|
|||||
|
2018
Q1 | $29.7M | Buy |
|
|||||
|
2017
Q4 | $27.5M | Buy |
|
|||||
|
2017
Q3 | $28.4M | Buy |
|
|||||
|
2017
Q2 | $6.77M | Sell |
|
|||||
|
2017
Q1 | $9.52M | Sell |
|
|||||
|
2016
Q4 | $21.6M | Buy |
|
|||||
|
2016
Q3 | $17.8M | Buy |
|
|||||
|
2016
Q2 | $3.56M | Buy |
|
|||||
|
2016
Q1 | $2.11M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $5.37M | Sell |
|
|||||
|
2014
Q2 | $8.69M | Buy |
|
|||||
|
2014
Q1 | $469K | Sell |
|
|||||
|
2013
Q4 | $3.7M | Buy |
|